Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)
06 mai 2019 08h30 HE
|
Resverlogix Corp
CALGARY, Alberta, May 06, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the recent publication of an article titled: “Multicenter Preclinical...
Liquidia Technologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update
31 oct. 2018 07h00 HE
|
Liquidia Technologies, Inc.
Completed enrollment of the safety portion of our Ph3 LIQ861 (INSPIRE) clinical trialTwo-week safety Ph3 LIQ861 data readout anticipated in the first quarter of 2019Dr. Stephen Bloch appointed as...
Improved Pulmonary Arterial Hypertension Mortality Risk ScoresShow Positive Impact of Ralinepag at the ISHLT 38th Annual Meeting & Scientific Sessions
14 avr. 2018 08h45 HE
|
International Society for Heart & Lung Transplantation
NICE, FR, April 14, 2018 (GLOBE NEWSWIRE) -- Today at the International Society for Heart and Lung Transplantation (ISHLT) 38th Annual Meeting & Scientific Sessions, Raymond Benza, MD, FAAC,...
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Platform Specialty Products Corporation Of Upcoming Deadline
16 mai 2016 15h41 HE
|
Rigrodsky Law, P.A
WILMINGTON, Del., May 16, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of Platform Specialty Products Corporation (NYSE:PAH)?Did you purchase your shares...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Platform Specialty Products Corporation - PAH
02 mai 2016 14h39 HE
|
The Rosen Law Firm PA
NEW YORK, May 02, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Platform Specialty Products...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Platform Specialty Products Corporation -- PAH
31 mars 2016 17h45 HE
|
Rigrodsky Law, P.A
WILMINGTON, Del., March 31, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of Platform Specialty Products Corporation (NYSE:PAH)?Did you purchase your shares...
Cardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines Agency
06 janv. 2016 08h00 HE
|
SteadyMed Therapeutics
VANCOUVER, British Columbia and SAN RAMON, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME), (TSX:COM) and SteadyMed Ltd. (Nasdaq:STDY), today announced that the...
SteadyMed Reports Recent Developments and Third Quarter 2015 Financial Results
12 nov. 2015 16h05 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value...
SteadyMed to Report Recent Developments and Third Quarter 2015 Financial Results
05 nov. 2015 07h30 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases...
SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting
28 oct. 2015 07h30 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value...